Stochastic kinetics of intracellular huntingtin aggregate formation
- PMID: 16699519
- DOI: 10.1038/nchembio792
Stochastic kinetics of intracellular huntingtin aggregate formation
Abstract
Neurodegeneration in Huntington disease is described by neuronal loss in which the probability of cell death remains constant with time. However, the quantitative connection between the kinetics of cell death and the molecular mechanism initiating neurodegeneration remains unclear. One hypothesis is that nucleation of protein aggregates containing exon I fragments of the mutant huntingtin protein (mhttex1), which contains an expanded polyglutamine region in patients with the disease, is the explanation for the infrequent but steady occurrence of neuronal death, resulting in adult onset of the disease. Recent in vitro evidence suggests that sufficiently long polyglutamine peptides undergo a unimolecular conformational change to form a nucleus that seeds aggregation. Here we use this nucleation mechanism as the basis to derive a stochastic mathematical model describing the probability of aggregate formation in cells as a function of time and mhttex1 protein concentration, and validate the model experimentally. These findings suggest that therapeutic strategies for Huntington disease predicated on reducing the rate of mhttex1 aggregation need only make modest reductions in huntingtin expression level to substantially increase the delay time until aggregate formation.
Comment in
-
Nucleation of huntingtin aggregation in cells.Nat Chem Biol. 2006 Jun;2(6):297-8. doi: 10.1038/nchembio0606-297. Nat Chem Biol. 2006. PMID: 16710335 No abstract available.
Similar articles
-
Nucleation of huntingtin aggregation in cells.Nat Chem Biol. 2006 Jun;2(6):297-8. doi: 10.1038/nchembio0606-297. Nat Chem Biol. 2006. PMID: 16710335 No abstract available.
-
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.Biochem Biophys Res Commun. 1999 Mar 16;256(2):361-6. doi: 10.1006/bbrc.1999.0337. Biochem Biophys Res Commun. 1999. PMID: 10079189
-
Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.J Neurochem. 2004 May;89(4):962-73. doi: 10.1111/j.1471-4159.2004.02376.x. J Neurochem. 2004. PMID: 15140195
-
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167. Essays Biochem. 2014. PMID: 25131594 Review.
-
Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.Prog Neurobiol. 2007 Nov;83(4):211-27. doi: 10.1016/j.pneurobio.2006.11.004. Epub 2007 Jan 22. Prog Neurobiol. 2007. PMID: 17240517 Review.
Cited by
-
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.Neurotherapeutics. 2015 Apr;12(2):352-63. doi: 10.1007/s13311-015-0338-x. Neurotherapeutics. 2015. PMID: 25652699 Free PMC article. Review.
-
Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells.Korean J Chem Eng. 2012 Jun;29(6):693-702. doi: 10.1007/s11814-012-0060-x. Korean J Chem Eng. 2012. PMID: 23565019 Free PMC article.
-
Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans.Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2021888118. doi: 10.1073/pnas.2021888118. Proc Natl Acad Sci U S A. 2021. PMID: 33836595 Free PMC article.
-
An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.Cell Death Dis. 2012 Aug 30;3(8):e382. doi: 10.1038/cddis.2012.121. Cell Death Dis. 2012. PMID: 22932724 Free PMC article. Review.
-
Prions Ex Vivo: What Cell Culture Models Tell Us about Infectious Proteins.Int J Cell Biol. 2013;2013:704546. doi: 10.1155/2013/704546. Epub 2013 Oct 26. Int J Cell Biol. 2013. PMID: 24282413 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
